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Dear Editor, 
Aging is a physiological process that is inevitable for all human bodies. By 2030, it has 
been estimated that almost 20 % of the population will be aged 65 years or older and cardio-
vascular diseases (CVD) will result in 40 % of all deaths in this demographic (North and Sin-
clair, 2012). Likewise, cardiovascular disease is more likely to be seen in accelerated aging 
syndromes, such as Hutchinson-Gilford progeria syndrome (HGPS), which further cements the 
fact that vascular aging is leading to a rise in CVD (Capell et al., 2007). Therefore, compre-
hending the intricate processes underlying the age related changes to the cardiovascular system 
is of utmost importance. 
The effect of aging on cardiovascular health is in part because aging perturbs a number of 
metabolic and hemodynamic mechanisms in the cardiovascular system in general and the vas-
cular endothelium in particular. Aging affects the vasculature by causing both structural and 
functional changes via increasing oxidative stress, premature cellular senescence and notably 
impairing the synthesis and release of endothelium-derived vasoactive molecules  (Ghebre et 
al., 2016). This leads to the release of harmful substances from the aging endothelium, which 
accelerates DNA damage, telomere erosion, senescence and stiffening of the vessel wall mak-
ing it susceptible to develop hypertension, atherosclerosis and other risk factors for cardiovas-
cular disease.  
Since the aging process is inescapable and will end up burdening healthcare in the not so 
distant future, researchers are striving to find ways to prevent aging in the first place. Prolonged 
periods of starvation leads to the formation of ketone bodies (KB), consisting of beta hy-
droxybyutarate (β-HB), which has shown to be therapeutic against neurological diseases (Paoli 
et al., 2014). Hence, the notion of ketone bodies preventing vascular aging can be a lucrative 
research venture which may ultimately lead to change in disease patterns of the geriatric popu-
lation. 
However, the method by which KB acts on the vascular system and on the aging process is 
largely unknown. The studies ave shown that β-HB might promote vascular cells quiescence. 
This predominantly inhibits both stress-induced premature senescence and replicative senes-
cence via p53 independent mechanism. Furthermore, a heterogenous nuclear ribonucleoprotein 
(hn RNA A1) has been identified to have a direct binding site for β-HB. Binding of β-HB to its 
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target site (hn RNA A1) significantly increases hn RNP A1 binding with octamer binding tran-
scriptional factor (Oct)4 mRNA, enhancing stabilization of Oct4 mRNA and Oct4 expression. 
The overall result is an increase in Lamin B1, a key-factor against DNA damage-induced se-
nescence. Researchers have also found that as senescent cells become unable to multiply and 
divide, β-HB in addition to promoting cell division can also prevent these cells from getting old 
(Han et al., 2018). 
Recently, a new dietary regimen is being adopted, popularized as the ‘ketogenic diet’(KD), 
which comprises of high fat and low carbohydrate food. This is set to replicate the effects of 
prolonged calorie restriction. The short term effects include the loss of body weight and an 
increase in KB production by the liver. The long term effects on cardiovascular system remain 
unknown (Sedej, 2017). 
Nonetheless, due to the fast and excessive loss of body fat, deleterious side effects of KD 
include menstrual abnormalities and osteoporosis in females. A β-HB mimetic would help in 
the long term, as it would not require the vigorous loss of body fat nor a tight diet control. But 
the production of such a drug is contingent on the fact that we are still unsure about how ketone 
bodies exert its protective effect on the vasculature (Martin et al., 2006). Considering that there 
is a dearth of research regarding long term effects of calorie restriction, ketogenic diet and a β-
HB therapeutic mimetic, there should be a renewed clinical interest in the modification of the 
human diet and preventive medicine, as we are advancing into the new decade of the millennia 
with an evolving elderly population. 
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